Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Pummer

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
International Urology and Nephrology|March 30, 2012
Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survivalMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
Urologia Internationalis|September 27, 2003
Findings and clinical course of a localized primitive peripheral neuroectodermal tumor of the kidneyHelga Habermann, Martin Benesch, Luigi Schips, et al.
European Urology|December 9, 2008
External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathologyRichard Zigeuner, Georg Hutterer, Thomas Chromecki, et al.
Urology|August 30, 2003
Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patientsRichard E Zigeuner, Katja Lipsky, Ildikò Riedler, et al.
Urology|October 26, 2010
Laparoscopic partial nephrectomy: a matched-pair comparison of the transperitoneal versus the retroperitoneal approachMartin Marszalek, Thomas Chromecki, Badereddin Mohamad Al-Ali, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2006
Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based studyTanja Eder, Ramona Mayer, Uwe Langsenlehner, et al.
The Journal of Urology|July 19, 2017
Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic ScoresMaximilian Seles, Florian Posch, Georg P Pichler, et al.
Urology|December 11, 2003
Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patientsLuigi Schips, Katja Lipsky, Richard Zigeuner, et al.
World Journal of Urology|September 4, 2013
The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapyLuis A Kluth, Shahrokh F Shariat, Christian Kratzik, et al.
The Journal of Urology|September 28, 2011
External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathologyMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
International Urology and Nephrology|March 30, 2012
Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survivalMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
Urologia Internationalis|September 27, 2003
Findings and clinical course of a localized primitive peripheral neuroectodermal tumor of the kidneyHelga Habermann, Martin Benesch, Luigi Schips, et al.
European Urology|December 9, 2008
External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathologyRichard Zigeuner, Georg Hutterer, Thomas Chromecki, et al.
Urology|August 30, 2003
Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patientsRichard E Zigeuner, Katja Lipsky, Ildikò Riedler, et al.
Urology|October 26, 2010
Laparoscopic partial nephrectomy: a matched-pair comparison of the transperitoneal versus the retroperitoneal approachMartin Marszalek, Thomas Chromecki, Badereddin Mohamad Al-Ali, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2006
Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based studyTanja Eder, Ramona Mayer, Uwe Langsenlehner, et al.
The Journal of Urology|July 19, 2017
Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic ScoresMaximilian Seles, Florian Posch, Georg P Pichler, et al.
Urology|December 11, 2003
Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patientsLuigi Schips, Katja Lipsky, Richard Zigeuner, et al.
World Journal of Urology|September 4, 2013
The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapyLuis A Kluth, Shahrokh F Shariat, Christian Kratzik, et al.
The Journal of Urology|September 28, 2011
External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathologyMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
Pageof 11